Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Download in electronic PDF format for $75
Abstract: The antidepressant effects of selective serotonin reuptake inhibitors are currently attributed to responses exhibited after periods of prolonged administration. Postulations have been formed accrediting the successful treatment of anxiety-related disorders with selective serotonin reuptake inhibitors to a similar mechanism of action as displayed in the treatment of depression. One of the drugs in this class is sertraline. This article provides a case report of a pediatric patient diagnosed with an anxiety disorder who was treated with transdermal sertraline. The compounding of dosage forms tailored to meet patient-specific needs may be an integral part in the successful delivery of selective serotonin reuptake inhibitor therapy.
Related Keywords:
transdermal administration, sertraline, anxiety disorders, children, case report, formulation, selective serotonin reuptake inhibitor, SSRI
Related Categories:
FORMULATIONS, MENTAL HEALTH, PEDIATRICS, CASE REPORTS, DOSAGE FORMS/DRUG CARRIERS
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Wynn Tom, Goetsch Daniel
|
May/Jun 2011
Pg. 200-203
|
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
|
Nov/Dec 2006
Pg. 418
|
Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
|
May/Jun 2017
Pg. 242-246
|
Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 318
|
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
|
Nov/Dec 2022
Pg. 468-472
|
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William, Helms Scott R
|
Sep/Oct 2008
Pg. 392-397
|
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Griffee Chris, Delano Amy
|
Mar/Apr 2012
Pg. 110-114
|
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Rudner Shara, Browne Paul
|
Nov/Dec 2010
Pg. 488-491
|
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
|
Sep/Oct 2021
Pg. 422-426
|
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A, Fokken Dawn
|
Sep/Oct 2009
Pg. 386-389
|
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 546
|
Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William, Angelle Patricea, Yoch Douglas
|
Jan/Feb 2009
Pg. 6-12
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
|
Nov/Dec 2008
Pg. 498-504
|
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
|
May/Jun 2011
Pg. 194-199
|
Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
|
Jul/Aug 2011
Pg. 302-307
|
Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
|
Sep/Oct 2023
Pg. 424-430
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment
Riepl Mike, Kaiser Joe
|
Sep/Oct 2023
Pg. 368-380
|
NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 446-448
|
| Return to Top |
